Announcements Trials

Browse Landscape

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Conditions

Multiple Myeloma 3576 Neoplasms, Plasma Cell 696 Lymphoma 531 Lymphoma, Non-Hodgkin 480 Leukemia, Lymphocytic, Chronic, B-Cell 409 Hodgkin Disease 405 Recurrence 404 Precursor Cell Lymphoblastic Leukemia-Lymphoma 375 Leukemia 373 Leukemia, Myeloid, Acute 363 Myelodysplastic Syndromes 331 Lymphoma, Large B-Cell, Diffuse 290 Lymphoma, Mantle-Cell 288 Lymphoma, Follicular 284 Lymphoma, B-Cell, Marginal Zone 256 Burkitt Lymphoma 249 Immunoglobulin Light-chain Amyloidosis 227 Myeloproliferative Disorders 226 Lymphoma, Large-Cell, Immunoblastic 223 Neoplasms 214 Hematologic Neoplasms 200 Primary Myelofibrosis 186 Leukemia, Myeloid, Chronic-Phase 182 Leukemia, Myeloid, Accelerated Phase 173 Lymphoma, T-Cell, Cutaneous 170 Waldenstrom Macroglobulinemia 164 Blast Crisis 162 Leukemia, Myelomonocytic, Chronic 158 Mycosis Fungoides 147 Sezary Syndrome 146

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Driving Under the Influence × Plasma cell × Clear all

NCT06659276 2024-10-26

MMR-PET-22-04

IRCCS Azienda Ospedaliero-Universitaria di Bologna

Driving Under the Influence, Multiple Myeloma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡